In vitro conditions for the study of the in vivo performance of sustained-release theophylline matrix tablets administered in fasted conditions and with a high-fat diet

Drug Development and Industrial Pharmacy

Volumn 25, Issue 11, 1999, Pages 1199-1203

  Andonaegui, M T ^a   Barria J L ^a   Thielemann, A M ^a   Seitz, C ^a   Gai, M N ^a  

^a UNIVERSITY OF CHILE   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOMER; EUDRAGIT; HYDROGENATED CASTOR OIL; THEOPHYLLINE;

ARTICLE; CORRELATION FUNCTION; DRUG BIOAVAILABILITY; DRUG SOLUBILITY; PH; SUSTAINED RELEASE PREPARATION; TABLET FORMULATION; TABLET MATRIX;

EID: 0032707847     PISSN: 03639045     EISSN: None     Source Type: Journal    
DOI: 10.1081/DDC-100102288     Document Type: Article

References (12)

1. N. Lordi, Sustained release dosage forms, in The Theory and Practice of Industrial Pharmacy (L. Lachman, H. Lieberman, and J. Kanig, Eds.), Lea and Febiger, Philadelphia, 1986, pp. 430-456.
2. R. Toothtaker and P. Welling, Annu. Rev. Pharmacol. Toxicol., 20, 173-199 (1980).
3. L. Williams, J. Davis, and D. Lowenthal, Med. Clin. North Am., 77(4), 815-829 (1993).
4. W. Charman, C. Porter, S. Mithani, and J. Dressman, J. Pharm. Sci., 86(3), 269-281 (1997).
5. M. N. Gai, A. M. Thielemann, and A. Arancibia, Int. J. Clin. Pharmacol. Ther. Toxicol., 31, 547-552 (1993).
6. M. N. Gai, A. Isla, M. T. Andonaegui, A. M. Thielemann, and C. Seitz, Int. J. Clin. Pharmacol. Ther., 35(12), 565-571 (1997).
7. L. Wearley, A. Karim, F. Pagone, J. Streicher, and A. Wickman, Drug Dev. Ind. Pharm., 14(1), 13-28 (1988).
8. M. P. Dandellot Keller, P. Buri, and E. Charollais, Pharm. Acta Helv., 67(3), 66-69 (1992).
9. P. K. Maturu, V. K. Prasad, W. N. Worsley, G. K. Shiu, and J. P. Skelly, J. Pharm. Sci., 75(12), 1205-1206 (1986).
10. U.S. Pharmacopeial Convention, The United States Pharmacopeia 23/National Formulary 18, Author, Rockville, MD, 1995.
11. S. Das and B. Gupta, Drug Dev. Ind. Pharm., 14(4), 537-544 (1988).
12. Carbopol Resins Handbook.